Complement Inhibition and COVID-19: The Story so Far

Sofiane Fodil, Djillali Annane

Open source

DOI: 10.2147/itt.s284830
Published: 2021-07
Container: ImmunoTargets and Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/itt.s284830,
  title = {Complement Inhibition and COVID-19: The Story so Far},
  author = {Sofiane Fodil and Djillali Annane},
  year = {2021},
  journal = {ImmunoTargets and Therapy},
  doi = {10.2147/itt.s284830},
  url = {https://doi.org/10.2147/itt.s284830}
}

RIS

TY  - JOUR
TI  - Complement Inhibition and COVID-19: The Story so Far
AU  - Sofiane Fodil
AU  - Djillali Annane
PY  - 2021
JO  - ImmunoTargets and Therapy
DO  - 10.2147/itt.s284830
UR  - https://doi.org/10.2147/itt.s284830
ER  -

APA

Fodil, S., & Annane, D. (2021). Complement Inhibition and COVID-19: The Story so Far. ImmunoTargets and Therapy. https://doi.org/10.2147/itt.s284830

Source records

crossref · retrieved 2026-09-24T19:47:23.861Z